Page 1297 - Williams Hematology ( PDFDrive )

1272 Part IX: Lymphocytes and Plasma Cells

135. Peter J, Ray GG: Infectious mononucleosis. Pediatr Rev 19:276, 1998. 140. Connor EM, Sperling RS, Gelber R, et al: Reduction of maternal-infant transmission
136. Walling DM, Flaitz CM, Nichols CM: Epstein-Barr virus replication in oral hairy leuko- of human immunodeficiency virus type 1 with zidovudine treatment. Pediatrics AIDS
plakia: Response, persistence, and resistance to treatment with valacyclovir. J Infect Dis Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173, 1994.
188:883, 2003. 141. Cengir SD, Ortac F, Soylemez F: Treatment and results of chronic toxoplasmosis. Anal-
137. Yao QY, Ogan P, Rowe M, et al: Epstein-Barr virus-infected B cells persist in the circu- ysis of 33 cases. Gynecol Obstet Invest 33:105, 1992.
lation of acyclovir-treated virus carriers. Int J Cancer 43:67, 1989. 142. Stray-Pedersen B: Treatment of toxoplasmosis in the pregnant mother and newborn
138. Goldberg GN, Fulginiti VA, Ray CG, et al: In utero Epstein-Barr virus (infectious child. Scand J Infect Dis 84:23, 1992.
mononucleosis) infection. JAMA 246:1579, 1981. 143. Nichols WG, Price TH, Gooley T, et al: Transfusion-transmitted cytomegalovirus infec-
139. Avgil M, Diav-Citrin O, Shechtman S, et al: Epstein-Barr virus in pregnancy: A pro- tion after receipt of leukoreduced blood products. Blood 101:4195, 2003.
spective controlled study. Reprod Toxicol 25:468, 2008. 144. Meyers JD: Prevention and treatment of cytomegalovirus infection after marrow trans-
plantation. Bone Marrow Transplant 3:95, 1988.

Kaushansky_chapter 82_p1261-1272.indd 1272 9/18/15 10:06 AM